Category: Healthcare and Life Sciences

Neuronetics and Greenbrook TMS Merger - Introduction In a groundbreaking move for the mental health industry, Neuronetics, Inc. (NASDAQ: STIM) and Greenbrook TMS Inc. (OTCMKTS: GBNHF) have announced...

Revance Therapeutics Goes Private in $900M Biotech M&A Deal Revance Therapeutics, a pioneer in developing Botox-like products, has agreed to a $900 million acquisition that will take the company...

AbbVie's Transformative Acquisition of Cerevel Therapeutics AbbVie's $8.7 billion acquisition of Cerevel Therapeutics is set to reshape the neuroscience landscape, unlocking innovative therapies and...

Rite Aid's Elixir Buyer Must Pay Additional $50M in Ch. 11 Sale In a pivotal move for its bankruptcy restructuring, embattled pharmacy chain Rite Aid has secured an additional $50 million from...

Pieris Pharma Stock Surges on Palvella Therapeutics Merger Deal Pieris Pharmaceuticals (PIRS) saw its stock soar by over 70% on July 24, 2024, following the announcement of an all-stock merger deal...

U.S. investment firm KKR, Singapore’s Temasek Holdings, and India’s Max Healthcare Institute are vying to buy TPG-backed chain of Care Hospitals in a deal worth over $1bn, Mint newspaper...

Source Author: unknown

Cano shares, which had been down nearly 7%, turned positive and closed up 32% after The Wall Street Journal reported on the talks with Humana and other unnamed parties, giving the company a market...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company dedicated to the discovery,...